Ultragenyx Pharmaceutical reported $-106569000 in EBIT for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -66772000 390K
Acceleron Pharma XLRN:US $ -63603000 6.01M
Agios Pharmaceuticals AGIO:US $ -91222000 5K
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Alnylam Pharmaceuticals ALNY:US $ -186254000 7.97M
Aptinyx Inc APTX:US $ -14290000 2.73M
Biocryst Pharmaceuticals BCRX:US $ -51377000 1.03M
Biomarin Pharmaceutical BMRN:US $ 13.86M 13.56M
Bluebird Bio BLUE:US $ -230839000 25.98M
Esperion Therapeutics ESPR:US $ -82824000 12.74M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Insmed INSM:US $ -83833000 10.7M
IONIS PHARMACEUT IONS:US $ -91971000 69.3M
Karyopharm Therapeutics KPTI:US $ -52373000 15.31M
Kyowa Hakko Kirin 4151:JP 14.96B 7.37B
Macrogenics MGNX:US $ -40279000 11.01M
Mirati Therapeutics MRTX:US $ -132421000 26.09M
Moderna Inc MRNA:US 1.27B 1.54B
Neurocrine Biosciences NBIX:US $ 31.5M 40.3M
Ptc Therapeutics PTCT:US $ -98493000 345K
Puma Biotechnology PBYI:US $ 20.15M 31.3M
Regeneron Pharmaceuticals REGN:US $ 1112.7M 54.3M
Sarepta Therapeutics SRPT:US $ -141865000 28.85M
Ultragenyx Pharmaceutical RARE:US $ -106569000 10.49M
Vertex Pharmaceuticals VRTX:US $ -33.54M 917.47M
Vital Therapies VTL:US $ -32387000 18.2M
Xoma XOMA:US $ -6427000 30.3M